Relevant bibliographies by topics / Mycoplasma diseases in animals

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Mycoplasma diseases in animals'

Author: Grafiati
Published: 4 June 2021
Last updated: 29 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Mycoplasma diseases in animals.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Mycoplasma diseases in animals"

1

Shastin, Pavel, Vasilii Savinov, Andrei Kapustin, Anton Yuzakov, and Alexey Laishevtsev. "Mycoplasmosis of farm animals." BIO Web of Conferences 51 (2022): 03002. http://dx.doi.org/10.1051/bioconf/20225103002.

Full text
Abstract:
The article presents an overview characterizing the spread of Mycoplasma infections among various kinds of farm animals. It also demonstrates the urgency of the pathogen of the disease - Mycoplasma spp., its characteristics and structural features, which provide significant differences from other types of microorganisms. Most species of Mycoplasma spp. are strictly specific to the host, but some of them pose a danger to humans. Mycoplasmas in animals cause diseases ranging from acute forms of the disease to an asymptomatic course. With the development of pathology, damage to various organs and tissues is observed, which indicates a high tropism of the pathogen, which contributes to the development of a generalized form of pathology. The most susceptible is the respiratory and reproductive tract, as a result of which farms are inflicted with significant economic damage. At the same time, some of the mycoplasmas build a symbiotic relationship with the host organism. Attempts to use antimicrobial therapy, including in various combinations, do not always lead to a positive result, which is due to the development of antibiotic resistance of the pathogen. Thanks to the change in the genome, mycoplasmas have become the smallest bacteria capable of self-replication. Mycoplasmas are classified as parasites or symbionts of animals, insects and plants, while the disease itself is opportunistic. Diagnosis of the disease consists mainly of three methods: serological, molecular biological and bacteriological, which are often used simultaneously. The cultivation of mycoplasmas has its own characteristic difficulties and features due to the structure of bacteria.
APA, Harvard, Vancouver, ISO, and other styles
2

Lührmann, Anke, Ursula Deiters, Julia Skokowa, Michaela Hanke, Johannes E. Gessner, Peter F. Mühlradt, Reinhard Pabst, and Thomas Tschernig. "In Vivo Effects of a Synthetic 2-Kilodalton Macrophage-Activating Lipopeptide of Mycoplasma fermentans after Pulmonary Application." Infection and Immunity 70, no. 7 (July 2002): 3785–92. http://dx.doi.org/10.1128/iai.70.7.3785-3792.2002.

Full text
Abstract:
ABSTRACT Mycoplasmas can cause interstitial pneumonias inducing critical illness in humans and animals. Mycoplasma infections are characterized by an influx of neutrophils, followed by an accumulation of macrophages and lymphocytes. The present study deals with the question of which mycoplasmal components cause this host reaction. The mycoplasma-derived, macrophage-activating lipopeptide 2S-MALP-2 was used to mimic the sequelae of a mycoplasma infection. To this end, 2S-MALP-2 was intratracheally instilled into the lungs of Lewis rats, and the bronchoalveolar lavage cells were examined at different times after different doses of 2S-MALP-2. Application of 2.5 μg induced a pronounced leukocyte accumulation in the bronchoalveolar space. At 24 h after 2S-MALP-2 administration, the majority of leukocytes consisted of neutrophils, followed by macrophages, peaking on days 2 and 3. Lymphocyte numbers, although amounting to only a few percent of the total bronchoalveolar lavage cells, also increased significantly, with maximal lymphocyte accumulation occurring by 72 h after instillation. The leukocyte count of the lung interstitium was increased on day 3 after treatment. After 10 days all investigated cell populations returned to control levels. Transient chemotactic activity for neutrophils was detected in the bronchoalveolar lavage fluid early after 2S-MALP-2 application, followed by monocyte chemoattractant protein-1 activity (MCP-1) in lung homogenates. MCP-1 was produced by bronchoalveolar lavage cells upon stimulation with 2S-MALP-2. Our data indicate that mycoplasmal lipoproteins and lipopeptides are probably the most relevant mycoplasmal components for the early host reaction. The primary target cells are likely to be the alveolar macrophages liberating chemokines, which attract further leukocytes.
APA, Harvard, Vancouver, ISO, and other styles
3

goltsov, Valery, Larisa Padilo, and Oksana Biryukova. "Comparative Therapy of Animal and Bird Diseases Caused by Mycoplasmas." BIO Web of Conferences 43 (2022): 02033. http://dx.doi.org/10.1051/bioconf/20224302033.

Full text
Abstract:
Mycoplasmas are the cause of many pathologies, both of various species of animals and birds. The minimum inhibitory concentrations (MICs) of enrofloxacin, difloxacin, oxytetracycline, chlortetracycline, doxycycline, tylosin, tilmycosin, tilvalosin, tiamulin, florfenicol, lincomycin, spectinomycin and 2 combinations (spectinomycin and lincomycin) with the isolates of Myecoplasma sympathy were significantly different. Elevated MICs of tilmicosin were observed in both M. synoviae and M. gallisepticum isolates (MIC values> = 64 μg/ml), and this was observed in all isolates with high MICs of tylosin. The increase in the MIC of lincomycin was mainly associated with the increase in the MIC of tilmicosin. In vitro susceptibility testing of 50 M. gallisepticum strains isolated in Israel in the period of 1997-2010 carried out by a group of scientists led by Gerchman I. showed that acquired resistance to tylosin, as well as to tilmicosin, is present in 50 % of them. Moreover, 72 % (13/18) of the strains isolated from clinical specimens since 2006 showed acquired resistance to enrofloxacin, tylosin and tilmicosin. All isolates with MIC> = 0.63 μg/ml for tylosin and MIC> = 1.25 μg/ml for tilmycosin have one of these mutations, which indicates a significant role in reducing the sensitivity of M. gallisepticum to 16-membered macrolides. Fluoroquinolones, tilmicosin, tulathromycin, chlortetracycline, doxycycline and oxytetracycline are effective against Mannheimia haemolytica and Mycoplasma, which are the main causative agents of respiratory infections in lambs. Antimicrobial resistance of Mycoplasma bovis isolates to antibacterial drugs is not high. With the exception of tilmicosin, all isolates were highly susceptible to the tested antimicrobials (oxytetracycline and florfenicol). Tilmicosin and oxytetracycline are effective in treating respiratory diseases in young calves, even if they are affected by Mycoplasma spp. Tilmicosin is more effective in eliminating the clinical signs of mycoplasmosis. Treatment of mycoplasma respiratory syndrome with tulathromycin resulted in slightly higher (P = 0.009) therapeutic success (87.9 % and 80 %, respectively) than initial treatment with enrofloxacin (70.2 % and 62.5 %, respectively). Animals treated with tulathromycin also received fewer follow-up treatments and increased weight gain compared to animals treated with enrofloxacin. Tulatromycin was evaluated in the treatment of pneumonia in weaning pigs intranasally inoculated with Mycoplasma hyopneumoniae. Tulatromycin was also quite effective. Use of broad-spectrum drugs, which include tilmicosin, is also promising. Therefore, the therapeutic efficacy of the analyzed drugs used for the treatment of mycoplasmosis, both in birds and animals (cattle, small ruminants, and pigs), depends both on the drugs used and on etiological agents. A significant role in the effectiveness of treatment with certain drugs is played by the infections accompanying mycoplasmosis.
APA, Harvard, Vancouver, ISO, and other styles
4

Nir-Paz, Ran, Marie-Christine Prévost, Pierre Nicolas, Alain Blanchard, and Henri Wróblewski. "Susceptibilities of Mycoplasma fermentans and Mycoplasma hyorhinis to Membrane-Active Peptides and Enrofloxacin in Human Tissue Cell Cultures." Antimicrobial Agents and Chemotherapy 46, no. 5 (May 2002): 1218–25. http://dx.doi.org/10.1128/aac.46.5.1218-1225.2002.

Full text
Abstract:
ABSTRACT Mycoplasmas, which are bacteria that are devoid of a cell wall and which belong to the class Mollicutes, are pathogenic for humans and animals and are frequent contaminants of tissue cell cultures. Although contamination of cultures with mycoplasma can easily be monitored with fluorescent dyes that stain DNA and/or with molecular probes, protection and decontamination of cultures remain serious challenges. In the present work, we investigated the susceptibilities of Mycoplasma fermentans and Mycoplasma hyorhinis to the membrane-active peptides alamethicin, dermaseptin B2, gramicidin S, and surfactin by growth inhibition and lethality assays. In the absence of serum, the four peptides killed mycoplasmas at minimal bactericidal concentrations that ranged from 12.5 to 100 μM, but in all cases the activities were decreased by the presence of serum. As a result, under standard culture conditions (10% serum) only alamethicin and gramicidin S were able to inhibit mycoplasma growth (MICs, 50 μM), while dermaseptin B2 and surfactin were ineffective. Furthermore, 8 days of treatment of HeLa cell cultures experimentally contaminated with either mycoplasma species with 70 μM enrofloxacin cured the cultures of infection, whereas treatment with alamethicin and gramicidin S alone was not reliable because the concentrations and treatment times required were toxic to the cells. However, combination of alamethicin or gramicidin S with 70 μM enrofloxacin allowed mycoplasma eradication after 30 min or 24 h of treatment, depending on the mycoplasma and peptide considered. HeLa cell cultures experimentally infected with mycoplasmas should prove to be a useful model for study of the antimycoplasma activities of antibiotics and membrane-active peptides under conditions close to those found in vivo.
APA, Harvard, Vancouver, ISO, and other styles
5

Dudek, Katarzyna, Dariusz Bednarek, Ewelina Szacawa, and Roger D. Ayling. "Screening of the Cervidae family in Poland for Mycoplasma species." Journal of Veterinary Research 60, no. 4 (December 1, 2016): 399–402. http://dx.doi.org/10.1515/jvetres-2016-0059.

Full text
Abstract:
Abstract Introduction: Several Mycoplasma species can cause severe diseases in ruminant hosts, some of which are the diseases listed by the World Organisation for Animal Health (OIE). The role of the Cervidae family in carrying and transmitting ruminant mycoplasma infections in Poland is unknown. Material and Methods: Antibody and antigen detection tests for the main mycoplasma species that can affect wild ruminants were performed on 237 samples (serum, nasal swab, bronchoalveolar lavage, and lung) collected from 161 animals during 2011-2014. The samples were obtained from a cull of healthy population of deer which included: 96 red deer (Cervus elaphus elaphus), 19 fallow deer (Dama dama), and 46 roe deer (Capreolus capreolus). Results: Serological screening tests revealed positive reactions to Mycoplasma bovis in one sample and to Mycoplasma capricolum subsp. capripneumoniae in three samples; however, these three samples were negative by immunoblotting. Other antibody and antigen detection tests demonstrated negative results. Conclusion: Currently wild cervids in Poland do not play a significant role in transmitting mycoplasma infections to domestic animals, but they remain a potential risk.
APA, Harvard, Vancouver, ISO, and other styles
6

Nicholas, R. A. J., R. D. Ayling, and L. McAuliffe. "Vaccines for Mycoplasma Diseases in Animals and Man." Journal of Comparative Pathology 140, no. 2-3 (February 2009): 85–96. http://dx.doi.org/10.1016/j.jcpa.2008.08.004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Piec, Grazyna, Jelena Mirkovitch, Silvia Palacio, Peter F. Mühlradt, and Rolf Felix. "Effect of MALP-2, a Lipopeptide fromMycoplasma fermentans, on Bone Resorption In Vitro." Infection and Immunity 67, no. 12 (December 1, 1999): 6281–85. http://dx.doi.org/10.1128/iai.67.12.6281-6285.1999.

Full text
Abstract:
ABSTRACT Mycoplasmas may be associated with rheumatoid arthritis in various animal hosts. In humans, mycoplasma arthritis has been recorded in association with hypogammaglobulinemia. Mycoplasma fermentans is one mycoplasma species considered to be involved in causing arthritis. To clarify which mycoplasmal compounds contribute to the inflammatory, bone-destructive processes in arthritis, we used a well-defined lipopeptide, 2-kDa macrophage-activating lipopeptide (MALP-2) from M. fermentans, as an example of a class of macrophage-activating compounds ubiquitous in mycoplasmas, to study its effects on bone resorption. MALP-2 stimulated osteoclast-mediated bone resorption in murine calvaria cultures, with a maximal effect at around 2 nM. Anti-inflammatory drugs inhibited MALP-2-mediated bone resorption by about 30%. This finding suggests that MALP-2 stimulates bone resorption partially by stimulating the formation of prostaglandins. Since interleukin-6 (IL-6) stimulates bone resorption, we investigated IL-6 production in cultured calvaria. MALP-2 stimulated the liberation of IL-6, while no tumor necrosis factor was detectable. Additionally, MALP-2 stimulated low levels of NO in calvaria cultures, an effect which was strongly increased in the presence of gamma interferon, causing an inhibition of bone resorption. MALP-2 stimulated the bone-resorbing activity of osteoclasts isolated from long bones of newborn rats and cultured on dentine slices without affecting their number. In bone marrow cultures, MALP-2 inhibited the formation of osteoclasts. It appears that MALP-2 has two opposing effects: it increases the bone resorption in bone tissue by stimulation of mature osteoclasts but inhibits the formation of new ones.
APA, Harvard, Vancouver, ISO, and other styles
8

Baranowski, Eric, Sébastien Guiral, Eveline Sagné, Agnès Skapski, and Christine Citti. "Critical Role of Dispensable Genes in Mycoplasma agalactiae Interaction with Mammalian Cells." Infection and Immunity 78, no. 4 (February 1, 2010): 1542–51. http://dx.doi.org/10.1128/iai.01195-09.

Full text
Abstract:
ABSTRACT Mycoplasmas are minimal bacteria whose genomes barely exceed the smallest amount of information required to sustain autonomous life. Despite this apparent simplicity, several mycoplasmas are successful pathogens of humans and animals, in which they establish intimate interactions with epithelial cells at mucosal surfaces. To identify biological functions mediating mycoplasma interactions with mammalian cells, we produced a library of transposon knockout mutants in the ruminant pathogen Mycoplasma agalactiae and used this library to identify mutants displaying a growth-deficient pheonotype in cell culture. M. agalactiae mutants displaying a 3-fold reduction in CFU titers to nearly complete extinction in coculture with HeLa cells were identified. Mapping of transposon insertion sites revealed 18 genomic regions putatively involved in the interaction of M. agalactiae with HeLa cells. Several of these regions encode proteins with features of membrane lipoproteins and/or were involved in horizontal gene transfer with phylogenetically distant pathogenic mycoplasmas of ruminants. Two mutants with the most extreme phenotype carry a transposon in a genomic region designated the NIF locus which encodes homologues of SufS and SufU, two proteins presumably involved in [Fe-S] cluster biosynthesis in Gram-positive bacteria. Complementation studies confirmed the conditional essentiality of the NIF locus, which was found to be critical for proliferation in the presence of HeLa cells and several other mammalian cell lines but dispensable for axenic growth. While our results raised questions regarding essential functions in mycoplasmas, they also provide a means for studying the role of mycoplasmas as minimal pathogens.
APA, Harvard, Vancouver, ISO, and other styles
9

Simecka, Jerry, Xiangle Sun, Nicole Dobbs, Sheetal Bodhankar, and Harlan Jones. "Dendritic cells are the major antigen presenting cells in inflammatory lesions of murine mycoplasma respiratory disease and contribute to disease severity (P3306)." Journal of Immunology 190, no. 1_Supplement (May 1, 2013): 134.6. http://dx.doi.org/10.4049/jimmunol.190.supp.134.6.

Full text
Abstract:
Abstract Mycoplasmas cause chronic respiratory diseases in animals and humans, and vaccine development has been problematic. T cell responses were shown to confer protection as well as promote immunopathology in murine mycoplasma pneumonia. Because T cells play a critical role, the role of antigen presenting cells (APC) was examined as they likely influence either an increase in disease severity or promote protective immunity. The roles of APC, such as dendritic cells (DC) and macrophages, in mycoplasma disease are currently unknown. In this study, we examined the ability pulmonary APC populations and their contribution to T cell responses during disease pathogenesis. Both macrophages and DC increased in the lungs of mice after infection. These cell populations showed different patterns of cytokine mRNA expression, supporting the idea that these cells have different impacts on immunity in response to infection. In fact, DC from the lungs of infected mice were most capable of stimulating mycoplasma-specific T helper (Th) cell responses in vitro. In vivo, DC cells were co-localized with Th cells in inflammatory lesions in the lungs of mycoplasma-infected mice. Intratracheal inoculation of mycoplasma antigen-pulsed DC resulted in increased disease severity after subsequent infection. Thus, DC appear to be the major APC population responsible for pulmonary T cell stimulation in mycoplasma-infected mice, and these DC likely contribute to responses impacting disease pathogenesis.
APA, Harvard, Vancouver, ISO, and other styles
10

Yancey, Anthony L., Harold L. Watson, Sam C. Cartner, and Jerry W. Simecka. "Gender Is a Major Factor in Determining the Severity of Mycoplasma Respiratory Disease in Mice." Infection and Immunity 69, no. 5 (May 1, 2001): 2865–71. http://dx.doi.org/10.1128/iai.69.5.2865-2871.2001.

Full text
Abstract:
ABSTRACT Gender is a significant factor in determining the susceptibility to and severity of pulmonary diseases in both humans and animals. Murine respiratory mycoplasmosis (MRM), due to Mycoplasma pulmonisinfection, is an excellent animal model for evaluation of the role of various host factors on the development of acute or chronic inflammatory lung diseases. MRM has many similarities to mycoplasma respiratory disease in humans. The purpose of the present study was to determine whether gender has a significant impact on lung disease due to M. pulmonis infection in mice. It was demonstrated that male mice consistently developed more severe disease in the lung parenchyma than did female mice. There was no gender difference in disease severity along the airways or any difference in mycoplasma numbers in lungs of male and female mice. Furthermore, surgical removal of reproductive organs reduced the severity of mycoplasma disease and the numbers of mycoplasma organisms recovered from lungs. Thus, gender plays a significant role in determining the severity of M. pulmonis disease. In fact, the gender of the host was a major factor in determining whether an acute or chronic inflammatory lung disease developed after infection with M. pulmonis.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Mycoplasma diseases in animals"

1

Punyapornwithaya, Veerasak. "Molecular epidemiology of mycoplasma mastitis outbreak." Pullman, Wash. : Washington State University, 2010. http://www.dissertations.wsu.edu/Dissertations/Spring2010/v_punyapornwithaya_042110.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Van, der Merwe Elizabeth Frances. "Preliminary investigations into ostrich mycoplasmas : identification of vaccine candidate genes and immunity elicited by poultry mycoplasma vaccines." Thesis, Stellenbosch : Stellenbosch University, 2006. http://hdl.handle.net/10019.1/17411.

Full text
Abstract:
Thesis (MSc)--University of Stellenbosch, 2006.
ENGLISH ABSTRACT: Ostrich farming is of significant economical importance in South Africa. Three ostrich mycoplasmas, Ms01, Ms02 and Ms03 have been identified previously, and were provisionally named ‘Mycoplasma struthiolus’ (Ms) after their host Struthio camelus. Ostrich mycoplasmas are the major causative organisms of respiratory diseases, and they cause stock losses, reduced production and hatchability, and downgrading of carcasses and therefore lead to large economic losses to the industry. In order to be pathogenic to their host, they need to attach through an attachment organelle, the so-called tip structure. This structure has been identified in the poultry mycoplasma, M. gallisepticum, and is made up of the adhesin GapA and adhesin-related CrmA. Currently, no ostrich mycoplasma vaccine is commercially available and for this reason the need to develop one has arisen. Therefore the first part of this study was dedicated to the identification and isolation of vaccine candidate genes in the three ostrich mycoplasmas. Four primer approaches for polymerase chain reactions (PCR’s), cloning and sequencing, were used for the identification of adhesin or adhesin-related genes from Ms01, Ms02 and Ms03. The primer approaches revealed that the target genes could not be identified due to the high diversity of sequences that were generated. Therefore sequences were also compared with those of other mycoplasma species in BLAST searches. Results showed that the most significant hit was with the human pathogen M. hominis oppD, which is located in the same operon as the membrane protein P100 involved in adhesion. Other hits were with ABC transporters which may also play a role in cytadhesion. The second part of this study was aimed at testing whether two poultry mycoplasma vaccines, M. synoviae and M. gallisepticum, can be used in ostriches to elicit immune responses until an ostrich mycoplasma vaccine has been developed. Ostriches on three farms of different age groups in the Oudsthoorn district were therefore vaccinated with these vaccines in a vaccine trial. The enzymelinked immunosorbent assay (ELISA) was used to test the level of antibody response. Results showed that both vaccines elicited an immune response in all three age groups. A high percentage of the ostriches reacted positively, which indicates that both vaccines elicit antibody responses and may therefore give protection against ostrich mycoplasma infections.
AFRIKAANSE OPSOMMING: Volstruisboerdery is ‘n belangrike ekonomiese sektor in Suid-Afrika. Drie volstruismikoplasmas, Ms01, Ms02 en Ms03, is voorheen geïdentifiseer en voorlopig ‘Mycoplasma struthiolus’ (Ms) benaam na aanleiding van hul gasheer, Struthio camelus. Volstruismikoplasmas is die grootste oorsaaklike organismes van respiratoriese siektes, kudde verliese en die afgradering van karkasse wat lei tot groot ekonomiese verliese in die volstruisbedryf. Ten einde patogenies vir die gasheer te wees, moet mikoplasmas deur middel van ‘n aanhegtingsmeganisme vasheg – die sogenaamde puntvormige struktuur. Hierdie struktuur is in die pluimvee mikoplasma M. gallisepticum geïdentifiseer, en bestaan uit aanhegting proteïen GapA en die aanhegting verwante proteïen CrmA. Tans is geen volstruismikoplasma entstof kommersieel beskikbaar nie, en derhalwe het die behoefte ontstaan om so ‘n entstof te ontwikkel. Die eerste gedeelte van hierdie studie is dus gewy aan die identifisering en isolering van entstof kandidaat gene in al drie volstruismikoplasmas. Vier inleier benaderings vir polimerase ketting reaksies (PKR), klonering asook geenopeenvolging bepalings vir die identifisering van aanhegting of aanhegting verwante gene vanuit Ms01, Ms02 en Ms03 is gebruik. Die inleier benaderings het getoon dat die teikengene nie geïdentifiseer kon word nie as gevolg van hoë variasie in die gegenereerde geenopeenvolgings. Derhalwe is geenopeenvolgings met ander mikoplasma spesies deur middel van BLAST soektogte vergelyk. Resultate het getoon dat die betekenisvolste ooreenstemming dié met die menslike patogeen M. hominis oppD was, wat deel vorm van die membraan proteïen P100 operon wat betrokke is by aanhegting. Ander ooreenstemmings sluit ABC transporters in wat moontlik betrokke kan wees by aanhegting. Die tweede gedeelte van hierdie studie het ten doel gehad om te toets of twee pluimvee mikoplasma entstowwe, M. synoviae en M. gallisepticum, gebruik kan word in volstruise om immuunresponse te ontlok tot tyd en wyl ‘n volstruismikoplasma entstof ontwikkel is. Volstruise vanaf drie plase in verskillende ouderdomsgroepe in die Oudtshoorn distrik was ingeënt met hierdie entstowwe in ‘n entstof proefneming. Die ensiem-afhanklike immuno-absorpsie essaï (ELISA) was gebruik om antiliggaam response te toets. Die resultate het getoon dat beide entstowwe immuunresponse ontlok het in al drie ouderdomsgroepe. ‘n Groot persentasie van die volstruise het positief gereageer wat ‘n aanduiding is dat beide entstowwe immuunresponse ontlok het en kan dus beskerming bied teen volstruismikoplasma infeksies.
APA, Harvard, Vancouver, ISO, and other styles
3

Robinson, Sally Rae. "Isolation, characterisation and molecular typing of feline mycoplasma species." Connect to thesis, 2009. http://repository.unimelb.edu.au/10187/5512.

Full text
Abstract:
The exact role of mycoplasma in feline ocular and respiratory disease is not yet understood. The results of previous studies are contradictory in this regard. There is some evidence to suggest that M. felis has a pathogenic role in such diseases, but it is inconclusive.
The aim of this study was to investigate the prevalence and anatomical distribution of mycoplasmas in a population of shelter cats, to determine which species were present, and establish the association of their presence with ocular or respiratory disease.
The prevalence of mycoplasma in the 110 cats examined was 71.8%, as determined by in vitro culture. Mycoplasma was most commonly isolated from the pharynx, followed by the bronchus and conjunctiva. In infected cats, mycoplasmas were likely to be isolated from multiple anatomical sites.
The polymerase chain reaction (PCR) was used to amplify part of the 16S rRNA gene, and the mutation scanning technique non-isotopic single-strand conformation polymorphism (SSCP) was utilised to delineate mycoplasma isolates based on nucleotide sequence variation. PCR-SSCP proved to be a useful method to screen large numbers of samples for variation and to group them according to species.
The species of mycoplasma identified by nucleotide sequencing were M. felis and M. gateae. It was not determined whether it was possible to differentiate between M. gateae and M. arginini based on SSCP profile results with the target DNA region used due to their almost identical nucleotide sequence. This group of M. gateae/M. arginini served as a useful non-pathogenic comparison group to M. felis.
There was no statistically significant difference between M. felis and the M. gateae/M. arginini group with respect to prevalence or anatomic distribution. There was no evidence of any association of mycoplasma with disease linked to any of the anatomic locations studied.
Mycoplasmas were isolated from the lower respiratory tract in 42.7% of cats. The isolation of mycoplasmas from the lower respiratory tract of healthy cats has been reported once, but this is the first report of M. felis being isolated from this location in healthy cats. This finding indicates that the isolation of mycoplasmas from the lower respiratory tract is not sufficient evidence to implicate a role in respiratory disease.
Mycoplasmas were not significantly involved in ocular or respiratory disease in the population of cats studied. More likely, they are commensal organisms in the conjunctiva, pharynx and bronchus. Whether they are capable of playing an opportunistic role in disease, or what conditions may facilitate such a role remains to be determined.
APA, Harvard, Vancouver, ISO, and other styles
4

Carrington, Christopher Antony Paul. "The role of Mycoplasma species in bovine respiratory disease complex in feedlot cattle in South Africa." Electronic thesis, 2007. http://upetd.up.ac.za/thesis/available/etd-10312007-150332/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Strydom, Marliz. "The ostrich mycoplasma Ms02 partial genome assembly, bioinformatic analysis and the development of three DNA vaccines." Thesis, Stellenbosch : Stellenbosch University, 2013. http://hdl.handle.net/10019.1/80381.

Full text
Abstract:
Thesis (MSc)--Stellenbosch University, 2013.
ENGLISH ABSTRACT: The South African ostrich industry is under enormous threats due to diseases contracted by the ostriches. H5N2 virus (avian influenza) outbreaks the past two years have resulted in thousands of ostriches having to be culled. However, the more silent respiratory infectious agents of ostriches are the three ostrich-specific mycoplasmas. Named Ms01, Ms02, and Ms03, these three mycoplasmas are responsible for dramatic production losses each year, due to their intrusive nature and the fact that no vaccines are currently available to prevent mycoplasma infections in ostriches. The use of antibiotics does not eradicate the disease completely, but only alleviates symptoms. The ostrich industry commissioned investigations into the development of three specific vaccines using the relatively novel approach of DNA vaccination. The concept of DNA vaccine development is based on the availability of complete genome sequences of the pathogen against which the vaccine is to be developed. This is necessary in order to identify vaccine candidate genes through comparative genomic studies. The Ms02 genome has previously been sequenced, resulting in 28 large contiguous sequences. This thesis used the technique of Thermal Asymmetric Interlaced Polymerase Chain Reaction (TAIL-PCR) to attempt assembly of these 28 contiguous sequences. The number was reduced to 14 large contiguous sequences, which were then subjected to repetitive sequence analysis and open reading frame analysis. Bioinformatic software was also used to predict the origin of replication. The extent of repeats in the Ms02 genome is illustrated, as well as the problems with genome assembly when dealing with repetitive-rich and A+T-rich genomes as those of mycoplasmas. Previous studies determined the mycoplasma oppA gene to be a good vaccine candidate gene, due to its cytadherent properties. This thesis describes the development of three DNA vaccines containing the Ms02 oppA gene, and a preliminary attempt to prove expression of one of these vaccines in a cell culture-based system. The DNA vaccine vectors pCI-neo, VR1012, and VR1020 were chosen for the vaccine development. The Ms02 oppA gene was also cloned into the prokaryotic expression vector pGEX-4T-1 in order to express the OppA protein for purification. The purified protein may be used in future serological tests in ostrich vaccination trials. In this study the protein was used to elicit anti-OppA rabbit antibodies, which were used to attempt detection of the pCI-neo-driven OppA protein expression in an MDA cell line in a transfection study. However, preliminary findings could not detect expression, but did indicate that the currently used colorimetric western blot technique may not be sensitive enough. It is suggested that different cell lines need to be investigated. Further optimisations are also required to decrease the observed non-specific binding.
AFRIKAANSE OPSOMMING: Die Suid-Afrikaanse volstruisbedryf is onder geweldige druk vanweë siektes wat die volstruise bedreig. Die epidemie van die H5N2 virus (voëlgriep) in die afgelope twee jaar het veroorsaak dat duisende volstruise van kant gemaak moes word. Daar is egter nog ‘n bedreiging wat tot geweldige produksie verliese lei elke jaar: die respiratoriese infeksies wat versoorsaak word deur die drie volstruis mikoplasmas, genoem Ms01, Ms02 en Ms03. Geen entstowwe is tans beskibaar om die infeksies te voorkom nie, en behandeling met behulp van antibiotikas is nie effektief in die genesing van infeksie nie, maar help net om die simptome te verlig. Weens die erns van die saak, het die Suid-Afrikaanse volstruisbedryf ‘n ondersoek geloods na die ontwikkeling van enstowwe teen elkeen van die drie volstruis mikoplasmas. Die relatiewe nuwe benadering van DNA-entstof ontwikkeling was die strategiese keuse. Die beginsel van DNA-entstof ontwikkeling berus op die beskikbaarheid van die genoomvolgordes van die siekte-veroorsakende organisme waarteen die enstof ontwikkel word. Geskikte kandidaat entstof gene word so opgespoor met behulp van vergelykende studies met ander beskikbare genome. Die Ms02 genoomvolgorde is voorheen bepaal en word verteenwoordig deur 28 groot geenvolgorde fragmente. Die tegniek van Thermal Asymmetric Interlaced Polymerase Chain Reaction (TAIL-PCR) is gebruik om van die 28 fragmente aan mekaar te las. Die aantal fragmente is verminder na 14 groot geenvolgorde fragmente, wat vervolgens gebruik was om die omvang van herhalende volgordes in die genoom te bepaal, om nuwe leesrame te ondersoek, asook om die oorsprong van DNA replikasie op te spoor met behulp van bioinformatika sagteware. Die omvang van die herhalende aard van die Ms02 genoom word geïllustreer, asook die gepaardgaande probleme met die las van geenvolgorde fragmente wanneer met genome van veelvuldige herhalende volgordes, wat boonop A+T-ryk is, gewerk word, soos die van mikoplasmas. Vorige studies het die mikoplasma oppA geen geïdentifiseer as ‘n geskikte kandidaat entstof geen as gevolg van sy selaanhegting-eienskappe. Hierdie studie behels die invoeging van die Ms02 oppA geen in drie DNA-enstof vektore, naamlik pCI-neo, VR1012, en VR1020, asook die voorlopige poging om bewys van uitdrukking van een van die entstowwe in ‘n selkultuursisteem te bewerkstellig. Die geen is ook gekloneer in die prokariotiese ekspressie vektor pGEX-4T-1, ten einde die Ms02 OppA proteïen te isoleer. Die geïsoleerde proteïen kan in serologiese toetse in toekomstige volstruis enstof proewe gebruik word. In hierdie studie is die proteïen gebruik om konyn teenliggame teen dit op te wek, wat dan gebruik was om vir die pCI-neo-gedrewe ekspressie van die oppA geen te toets in ‘n selkultuur omgewing deur ‘n MDA sellyn te transfekteer. Die voorlopige resultate toon nie ekspressie van die OppA proteïen aan nie, maar het wel uitgelig dat die western blot tegniek wat tans gebruik word, dalk nie sensitief genoeg is nie. Dit kan belowend wees om ander tipes selle te toets. Verdere optimisering is ook nodig om die nie-spesifieke binding wat waargeneem is, te verlaag.
South African Ostrich Business Chamber
APA, Harvard, Vancouver, ISO, and other styles
6

Botes, Annelise. "Immunological and epidemiological investigations in South African ostriches and penguins." Thesis, Stellenbosch : Stellenbosch University, 2004. http://hdl.handle.net/10019.1/53747.

Full text
Abstract:
Dissertation (PhD)--University of Stellenbosch, 2004
ENGLISH ABSTRACT: Newcastle disease (NO) and mycoplasma infections in ostriches have considerable economic implications for the South African ostrich industry in that NO is a limiting factor in the export of ostrich products to the European Union and mycoplasma infections cause stock losses, reduced production, reduced hatchability and downgrading of carcasses. In the first section of this dissertation, the role of passively acquired and mucosal immunity in protection of ostrich chicks against Newcastle disease virus (NOV) was investigated. Ostrich hen serum IgG and yolk IgY were isolated and characterized, and the transfer of maternal anti-NOV antibodies to the egg yolk was determined using an enzyme-linked immunosorbent assay (ELISA). Results indicated that anti-NOV antibodies were successfully transferred from the ostrich hen to the egg yolk. In addition, ostrich IgA was isolated, characterized and rabbit anti-ostrich IgA antibodies produced and used for measuring mucosal anti- NOV IgA antibodies produced in response to mucosal vaccination. Results indicated that the live La Sota vaccine stimulates IgA production and thus mucosal immunity in ostrich chicks. In the second section of this dissertation, ostrich mycoplasmas were isolated and identified using 16S rRNA gene sequencing. These sequences indicated that ostriches carry three unique mycoplasmas, which are phylogenetically quite divergent. The 16S rRNA gene sequences of the ostrich mycoplasmas were subsequently used for the development of specific primers for the detection and diagnosis of mycoplasma infections in ostriches by PCR. The last section of this dissertation focuses on avian malaria in African penguins and the management of this disease during rehabilitation. The Foundation for the Conservation of Coastal Birds (SANCCOB) is a seabird rescue and rehabilitation centre, which is largely dedicated to the rehabilitation of diseased, injured and oiled penguins. Significant mortalities due to avian malaria occur at this facility. The aim of this study was the development of an ELISA for the purpose of assessing the natural levels of anti-Plasmodium antibodies in African penguins on entry into the SANCCOB facility and during rehabilitation. Results indicated significant increases in anti- Plasmodium antibody levels after entry, which was not influenced by oiling. Infection with malaria and not parasite recrudescence was viewed to be the cause of this increase, indicating a possible role of the SANCCOB facility in exposing penguins to avian malaria.
AFRIKAANSE OPSOMMING: Newcastlesiekte (NS) en mikoplasmainfeksies in voltruise het geweldige ekonomiese implikasies vir die Suid-Afrikaanse volstruisbedryf. Die rede hiervoor is dat NS 'n beperkende faktor in die uitvoer van volstruisprodukte na die Europese Unie is, en mikoplasmainfeksies tot kudde verliese, verlaagde produksie en uitbroei asook lae gradering van karkasse lei. In die eerste gedeelte van hierdie proefskrif is die rol van passiewe- en mukosale-immuniteit in die beskerming van volstruiskuikens teen NS virus (NSV) ondersoek. Volstruishenserum IgG en eier IgY is geïsoleer en gekarakteriseer en die oordrag van maternale anti-NSV antiliggame na die eier ondersoek met behulp van 'n 'enzyme-linked immunosorbent assay' (ELISA). Resultate het getoon dat anti-NSV antiliggame suksesvol van die hen na die eier oorgedra is. Volstruis IgA is ook geïsoleer, gekarateriseer en konyn anti-volstruis IgA antiliggame geproduseer wat gebruik is vir die bepaling van mukosale anti-NSV IgA antiliggame in reaksie op mukosale immunisering. Resultate het getoon dat lewendige La Sota entstof IgA produksie stimuleer en dus tot mukosale-immuniteit in volstruiskuikens lei. In die tweede gedeelte van hierdie proefskrif is volstruismikoplasmas geïsoleer en geïdentifiseer met behulp van 16S rRNA geenopeenvolgingsbepalings. Hierdie volgordes het getoon dat drie unieke mikoplasmas in volstruise voorkom wat filogeneties verskillend blyk te wees. Die 16S rRNA geenopeenvolgings van die volstruismikoplasmas is gebruik vir die ontwikkeling van spesifieke inleiers vir die PKR identifisering en diagnose van mikoplasmainfeksies in volstruise. Die laaste gedeelte van hierdie proefskrif fokus op voëlmalaria in die Afrika pikkewyn en die bestuur van hierdie siekte gedurende rehabilitasie. Die 'South African Foundation for the Conservation of Coastal Birds' (SANCCOB) is 'n seevoëlreddingsen rehabilitasie-sentrum vir siek, beseerde en ge-oliede pikkewyne. Hierdie sentrum het egter aansienlike vrektes as gevolg van voëlmalaria. In hierdie studie is 'n ELISA ontwikkel vir die bepaling van natuurlike anti-Plasmodium antiliggaamvlakke van pikkewyne by aankoms en tydens rehabilitasie by SANCCOB. Resultate het 'n toename in anti-Plasmodium antiliggaamvlakke getoon na toelating wat nie beïnvloed is deur olie nie. Hierdie toename kan toegeskryf word aan nuwe malariainfeksies en nie 'n heruitbraak van bestaande infeksies nie wat daarop dui dat pikkewyne aan voëlmalaria blootgestel word by die SANCCOB-sentrum.
APA, Harvard, Vancouver, ISO, and other styles
7

Brewster, Veronica Rose. "Towards an eradication strategy for mycoplasma hypneumoniae from the UK pig herd." Thesis, Royal Veterinary College (University of London), 2016. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.701680.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Persson, Anja M. "Molecular characterisation of Mycoplasma mycoides subsp. mycoides SC /." Uppsala : Dept. of Veterinary Microbiology, Swedish Univ. of Agricultural Sciences ([Institutionen för veterinärmedicinsk mikrobiologi], Sveriges lantbruksuniv.), 2002. http://epsilon.slu.se/avh/2002/91-576-6364-5.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Whalin, Rebekah Christine. "The Detection of Mycoplasmas in Migratory Birds." Miami University Honors Theses / OhioLINK, 2009. http://rave.ohiolink.edu/etdc/view?acc_num=muhonors1239986702.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Czifra, György. "Identification of Mycoplasma gallisepticum antigens with diagnostic and protective properties /." Uppsala : Swedish Univ. of Agricultural Sciences (Sveriges lantbruksuniv.), 1999. http://epsilon.slu.se/avh/1999/91-576-5900-1.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Mycoplasma diseases in animals"

1

Nicholas, Robin. Mycoplasma diseases of ruminants. Wallingford, Oxfordshire, UK: CABI, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

R, Nichols, ed. Mycoplasma diseases of ruminants: Disease, diagnosis and control. Wallingford: CABI, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Bölske, Göran. Respiratory mycoplasmoses in goats: Especially with regard to diagnosis of contagious caprine pleuropneumonia. Uppsala, Sweden: Swedish University of Agricultural Sciences, Dept. of Veterinary Microbiology, Section of Clinical Microbiology, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Lăng, Phạm Sỹ. Một só̂ bệnh mới do vi khuả̂n và Mycoplasma ở gia súc-gia cà̂m nhập nội và biện pháp phòng trị. Hà Nội: Nhà xuá̂t bản Nông nghiệp, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

1942-, Hamm Thomas E., and Chemical Industry Institute of Toxicology. Conference, eds. Complications of viral and mycoplasmal infections in rodents to toxicology research and testing. Washington [D.C.]: Hemisphere Pub. Corp., 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

W, Whitford Howard, Rosenbusch Ricardo F, Lauerman Lloyd Herman 1933-, and American Association of Veterinary Laboratory Diagnosticians. Mycoplasmosis Committee., eds. Micoplasmosis in animals: Laboratory diagnosis. Ames: Iowa State University Press, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

1931-, Hiruki C., ed. Tree mycoplasma and mycoplasma diseases. Edmonton: University of Alberta Press, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Maramorosch, Karl, and S. P. Raychaudhuri, eds. Mycoplasma Diseases of Crops. New York, NY: Springer New York, 1988. http://dx.doi.org/10.1007/978-1-4612-3808-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Nicholas, R., R. Ayling, and L. McAuliffe, eds. Mycoplasma diseases of ruminants. Wallingford: CABI, 2008. http://dx.doi.org/10.1079/9780851990125.0000.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

International Organization for Mycoplasmology. International Congress. Program and abstracts of the 8th International Congress of the IOM, 8-12 July, 1990, Istanbul, Turkey. [Istanbul?]: International Organization for Mycoplasmology, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Mycoplasma diseases in animals"

1

Liss, Alan. "Prospects for Rapid Identification of Spiroplasmas in Plants and Animals." In Mycoplasma Diseases of Crops, 103–11. New York, NY: Springer New York, 1988. http://dx.doi.org/10.1007/978-1-4612-3808-9_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Chae, Chan-hee, João Carlos Gomes Neto, Joaquim Segalés, and Marina Sibila. "Diagnosis of Mycoplasma hyopneumoniae infection and associated diseases." In Mycoplasmas in swine, 147–61. Wallingford: CABI, 2021. http://dx.doi.org/10.1079/9781789249941.0147.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Grace, Delia, Tadelle Dessie, Michel Dione, Henry Kiara, Anne Liljander, Jeff Mariner, Jan Naessens, et al. "Transboundary animal diseases." In The impact of the International Livestock Research Institute, 274–301. Wallingford: CABI, 2020. http://dx.doi.org/10.1079/9781789241853.0274.

Full text
Abstract:
Abstract Transboundary animal diseases (TADs) are highly contagious epidemics with the potential for very rapid spread, causing serious economic and sometimes public health consequences while threatening farmers' livelihoods. TADs often cause high morbidity and mortality in susceptible animal populations. Some TADs are also emerging infectious diseases, food-borne diseases and/or zoonoses: these are covered in other chapters. This chapter covers those high-impact, highly contagious animal diseases, such as foot-andmouth disease (FMD), that do not infect humans but do affect food and nutrition security and trade that the International Livestock Research Institute (ILRI) has been working on since the 1990s. These are: African swine fever (ASF), mycoplasma disease (both contagious bovine pleuropneumonia (CBPP) and contagious caprine pleuropneumonia (CCPP)), peste des petits ruminants (PPR) and Newcastle disease (ND). Other TADs, which were to a lesser degree the focus of ILRI research, are briefly mentioned (including FMD, classical swine fever (CSF) and rinderpest).
APA, Harvard, Vancouver, ISO, and other styles
4

Browning, G. F., M. S. Marenda, P. F. Markham, A. H. Noormohammadi, and K. G. Whithear. "Mycoplasma." In Pathogenesis of Bacterial Infections in Animals, 549–73. Oxford, UK: Wiley-Blackwell, 2010. http://dx.doi.org/10.1002/9780470958209.ch29.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Nicholas, Robin, and Samantha Baker. "Recovery of Mycoplasmas from Animals." In Mycoplasma Protocols, 37–43. Totowa, NJ: Humana Press, 1998. http://dx.doi.org/10.1385/0-89603-525-5:37.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Nicholas, Robin A. J., and Marco Giacometti. "Mycoplasma Infections." In Infectious Diseases of Wild Mammals and Birds in Europe, 372–80. Oxford, UK: Wiley-Blackwell, 2012. http://dx.doi.org/10.1002/9781118342442.ch29.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Atkinson, T. Prescott. "Mollicutes: Mycoplasma pneumoniae." In The Microbiome in Rheumatic Diseases and Infection, 103–11. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-79026-8_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Mendoza, Natalia, Parisa Ravanfar, Anita K. Shetty, Brenda L. Pellicane, Rosella Creed, Sara Goel, and Stephen K. Tyring. "Genital Mycoplasma Infection." In Sexually Transmitted Infections and Sexually Transmitted Diseases, 197–201. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-14663-3_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Arora, Y. K., and R. C. Sinha. "Plant Pathogenic Mycoplasmas: Morphological and Biochemical Characteristics." In Mycoplasma Diseases of Crops, 3–28. New York, NY: Springer New York, 1988. http://dx.doi.org/10.1007/978-1-4612-3808-9_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Oldfield, George N. "Ecological Associations of Spiroplasma Citri with Insects, Plants, and other Plant Mycoplasmas in the Western United States." In Mycoplasma Diseases of Crops, 175–91. New York, NY: Springer New York, 1988. http://dx.doi.org/10.1007/978-1-4612-3808-9_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Mycoplasma diseases in animals"

1

Ramirez-Corbera, AS, JA Hernández-Beriain, A. Rosas, and E. Girona. "THU0075 Mycoplasma pneumoniae infection and rheumatoid arthritis." In Annual European Congress of Rheumatology, Annals of the rheumatic diseases ARD July 2001. BMJ Publishing Group Ltd and European League Against Rheumatism, 2001. http://dx.doi.org/10.1136/annrheumdis-2001.952.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Balanetchi, Ludmila, Consuela Adam, Rodica Selevestru, Ianos Adam, Diana Rotaru-Cojocari, Liuba Neamtu, and Svetlana Sciuca. "Chlamydia pneumoniae and Mycoplasma pneumonia infection in children respiratory diseases." In ERS International Congress 2021 abstracts. European Respiratory Society, 2021. http://dx.doi.org/10.1183/13993003.congress-2021.pa1962.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kitajima, S., M. Kawano, H. Mutoh, I. Koni, H. Mabuchi, M. Matsumoto, and T. Seya. "THU0094 Experimental mycoplasma fermentans infection in rheumatoid synovial fibroblasts induces m161ag expression." In Annual European Congress of Rheumatology, Annals of the rheumatic diseases ARD July 2001. BMJ Publishing Group Ltd and European League Against Rheumatism, 2001. http://dx.doi.org/10.1136/annrheumdis-2001.971.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kokolova, L. M., L. Iu Gavrileva, and V. A. Bolshakova. "Prevention of parasitic diseases in young agricultural animals in Yakutia." In ТЕНДЕНЦИИ РАЗВИТИЯ НАУКИ И ОБРАЗОВАНИЯ. НИЦ «Л-Журнал», 2018. http://dx.doi.org/10.18411/lj-11-2018-125.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

"Diagnostics of diseases of farm animals in the "CORAL" expert systems." In AGRICULTURAL INFORMATION TECHNOLOGY AND ENGINEERING AGROINFO-2021. SFSCA RAS, 2021. http://dx.doi.org/10.26898/agroinfo-2021-80-84.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Cote, Daniel C. "Optical sensing and control in live animals for early detection of diseases." In CLEO: Applications and Technology. Washington, D.C.: OSA, 2014. http://dx.doi.org/10.1364/cleo_at.2014.af2b.4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

"Cholinergic deficit in olfactory bulbectomized animals as a model of neurodegenerative diseases." In Bioinformatics of Genome Regulation and Structure/ Systems Biology. institute of cytology and genetics siberian branch of the russian academy of science, Novosibirsk State University, 2020. http://dx.doi.org/10.18699/bgrs/sb-2020-404.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Valentovich, L. N., A. A. Muratova, Yu V. Shavela, M. A. Sikolenko, and A. E. Akhremchuk. "Sequencing and analysis of genomes of bacteria used to protect plants and animals from diseases." In 2nd International Scientific Conference "Plants and Microbes: the Future of Biotechnology". PLAMIC2020 Organizing committee, 2020. http://dx.doi.org/10.28983/plamic2020.264.

Full text
Abstract:
The main stages of work with perspective strains for protecting plants and animals from diseases are presented: genome sequencing and analysis, genetic construction of improved strains and checking their survival under model conditions.
APA, Harvard, Vancouver, ISO, and other styles
9

Segura, Rocio, Guadalupe Ortega, Joaquin Sosa, Marta Crespn, Celestino Gil, Trinidad Montes, Juan Vacas, and Maria del Rosario Navarro. "AB1409-HPR INFLUENCE OF THE COMPANION ANIMALS IN THE PERCEPTION OF OUTBREAKS IN RHEUMATOLOGICAL DISEASES." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.8177.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Saltan Fatma, Z. "Turkish medicinal and aromatic plants for the treatment of skin diseases both human and animals." In GA 2017 – Book of Abstracts. Georg Thieme Verlag KG, 2017. http://dx.doi.org/10.1055/s-0037-1608167.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Mycoplasma diseases in animals"

1

Yogev, David, Ricardo Rosenbusch, Sharon Levisohn, and Eitan Rapoport. Molecular Pathogenesis of Mycoplasma bovis and Mycoplasma agalactiae and its Application in Diagnosis and Control. United States Department of Agriculture, April 2000. http://dx.doi.org/10.32747/2000.7573073.bard.

Full text
Abstract:
Mycoplasma bovis and M. agalactiae are two phylogenetically related mycoplasmas which cause economically significant diseases in their respective bovine or small ruminant hosts. These organisms cause persistent asymptomatic infections that can result in severe outbreaks upon introduction of carrier animals into susceptible herds. Little is known about the mechanisms underlying mycoplasma-host interaction, variation in virulence, or of the factors enabling avoidance of the host immune system. In recent years it has become apparent that the ability of pathogenic microorganisms to rapidly alter surface antigenic structures and to fine tune their antigenicity, a phenomena called antigenic variation, is one of the most effective strategies used to escape immune destruction and to establish chronic infections. Our discovery of a novel genetic system, mediating antigenic variation in M. bovis (vsp) as well as in M. agalactiae (avg) served as a starting point for our proposal which included the following objectives: (i) Molecular and functional characterization of the variable surface lipoproteins (Vsp) system of M. bovis and comparison with the Vsp-counterpart in M. agalactiae (ii) Determination of the role of Vsp proteins in the survival of M. bovis when confronted by host defense factors, (iii) Assessment of Vsp-based genetic and antigenic typing of M. bovis and M. agalactiae for epidemiology of infection and (iv) Improvement of diagnostic tests for M. bovis and M. agalactiae based on the vsp-and vsp-analogous systems. We have carried out an extensive molecular characterization of the vsp system and unravelled the precise molecular mechanism responsible for the generation of surface antigenic variation in M. bovis. Our data clearly demonstrated that the two pathogenic mycoplasma species possess large gene families encoding variable lipoprotein antigens that apparently play an important role in immune evasion and in pathogen-host interaction during infection. Phase variable production of these antigens was found to be mediated by a novel molecular mechanism utilizing double site-specific DNA inversions via an intermediate vsp configuration. Studies in model systems indicate that phase variation of VspA is relevant in interaction between M. bovis and macrophages or monocytes, a crucial stage in pathogenesis. Using an ELISA test with captured VspA as an antigen, phase variation was shown to occur in vivo and under field conditions. Genomic rearrangements in the avg gene family of M. agalactiae were shown to occur in vivo and may well have a role in evasion of host defences and establishment of chronic infection. An epidemiological study indicated that patterns of vsp-related antigenic variation diverge rapidly in an M. bovis infected herd. Marked divergence was also found with avg-based genomic typing of M. agalactiae in chronically infected sheep. However, avg-genomic fingerprints were found to be relatively homogeneous in different animals during acute stages of an outbreak of Contagious Agalactiae, and differ between unrelated outbreaks. These data support the concept of vsp-based genomic typing but indicate the necessity for further refinement of the methodology. The molecular knowledge on these surface antigens and their encoding genes provides the basis for generating specific recombinant tools and serological methods for serodiagnosis and epidemiological purposes. Utilization of these methods in the field may allow differentiating acutely infected herds from chronic herds and disease-free herds. In addition the highly immunogenic nature of these lipoproteins may facilitate the design of protective vaccine against mycoplasma infections.
APA, Harvard, Vancouver, ISO, and other styles
2

Bett, Bernard, Delia Randolph, and John McDermott. Africa’s growing risk of diseases that spread from animals to people. Washington, DC: International Food Policy Research Institute, 2020. http://dx.doi.org/10.2499/p15738coll2.133762_28.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kokolova, L. M., L. Y. Gavrilieva, S. M. Stepanova, S. V. Dulova, and I. I. Romanov. RESEARCH OF PARASITIC DISEASES IN FISHING ANIMALS IN THE ECOSYSTEM OF THE FAR NORTH. Ljournal, 2019. http://dx.doi.org/10.18411/2108-1986-gelmint.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

EVGLEVSKAYA, E. P., and Al A. EVGLEVSKY. INNOVATIVE DEVELOPMENTS FOR THE PREVENTION OF ECONOMICALLY IMPORTANT DISEASES OF HIGHLY PRODUCTIVE ANIMALS IN INDUSTRIAL FARMING. Bulletin of the KSAA - 2019, 2019. http://dx.doi.org/10.18411/issn1997-0749.2019-01-09.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Splitter, Gary, Zeev Trainin, and Yacov Brenner. Lymphocyte Response to Genetically Engineered Bovine Leukemia Virus Proteins in Persistently Lymphocytic Cattle from Israel and the U.S. United States Department of Agriculture, July 1995. http://dx.doi.org/10.32747/1995.7570556.bard.

Full text
Abstract:
The goal of this proposal was to identify proteins of BLV recognized by lymphocyte subpopulations and determine the contribution of these proteins to viral pathogenesis. Our hypothesis was that BLV pathogenesis is governed by the T-cell response and that the immune system likely plays an important role in controlling the utcome of infection. Our studies presented in ths final report demonstrate that T cell competency declines with advancing stages of infection. Dramatic differences were observed in lymphocyte proliferation to recombinant proteins encoded by BLV gag (p12, p15, and p24) and env (gp30 and gp15) genes in different disease stages. Because retroviruses are known to mutate frequently, examinatin of infected cattle from both Israel and the United States will likely detect variability in the immune response. This combined research approach provides the first opportunity to selectively address the importance of T-cell proliferation to BLV proteins and cytokines produced during different stages of BLV infection. Lack of this information regarding BLV infection has hindered understanding lympocyte regulation of BLV pathogenesis. We have developed the essential reagents necessary to determine the prominence of different lymphocyte subpopulations and cytokines produced during the different disease stages within the natural host. We found that type 1 cytokines (IL-2 and IFN-g) increased in PBMCs from animals in early disease, and decreasd in PBMCs from animals in late disease stages of BLV infection, while IL-10, increased with disease progression. Recently, a dichotomy between IL-12 and IL-10 has emerged in regards to progression of a variety of diseases. IL-12 activates type 1 cytokine production and has an antagonistic effect on type 2 cytokines. Here, using quantitative competitive PCR, we show that peripheral blood mononuclear cells from bovine leukemia virus infected animals in the alymphocytotic disease stage express increased amount of IL-12 p40 mRNA. In contrast, IL-12 p40 mRNA expression by PL animals was significantly decreased compared to normal and alymphocytotic animals. To examine the functions of these cytokines on BLV expression, BLV tax and pol mRNA expression and p24 protein production were quantified by competitive PCR, and by immunoblotting, respectively. IL-10 inhibited BLV tax and pol mRNA expression by BLV-infected PBMCs. In addition, we determined that macrophages secret soluble factor(s) that activate BLV expression, and that secretion of the soluble factor(s) could be inhibited by IL-10. In contrast, IL-2 increased BLV tax and pol mRNA, and p24 protein production. These findings suggest that macrophages have a key role in regulating BLV expression, and IL-10 produced by BLV-infected animals in late disease stages may serve to control BLV expression, while IL-2 in the early stage of disease may activate BLV expression. PGE2 is an important immune regulator produced only by macrophages, and is known to facilitate HIV replication. We hypothesized that PGE2 may regulate BLV expression. Here, we show that cyclooxygenase-2 (COX-2) mRNA expression was decreased in PBMCs treated with IL-10, while IL-2 enhanced COX-2 mRNA expression. In contrast, addition of PGE2 stimulated BLV tax and pol mRNA expression. In addition, the specific COX-2 inhibitor, NS-398, inhibited BLV expression, while addition of PGE2 increased BLV tax expression regardless of NS-398. These findings suggest that macrophage derived cyclooxygenase -2 products, such as PGE2, may regulate virus expression and disease rogression in BLV infection, and that cytokines (IL-2 and IL-10) may regulate BLV expression through PGE2 production.
APA, Harvard, Vancouver, ISO, and other styles
6

Noga, Edward J., Angelo Colorni, Michael G. Levy, and Ramy Avtalion. Importance of Endobiotics in Defense against Protozoan Ectoparasites of Fish. United States Department of Agriculture, September 2003. http://dx.doi.org/10.32747/2003.7586463.bard.

Full text
Abstract:
Infectious disease is one of the most serious causes of economic loss in all sectors of aquaculture. There is a critical need to understand the molecular basis for protection against infectious disease so that safer, more reliable and more cost-effective strategies can be designed for their control. As part of this effort, the major goal of our BARD project was to determine the importance of endobiotics as a defense against protozoan ectoparasites in fish. Endobiotics, or antimicrobial polypeptides, are peptides and small proteins that are increasingly recognized as having a vital role in the innate defense of virtually all animals. One objective of our BARD project was to determine the antiparasitic potency of one specific group of endobiotics that were isolated from hybrid striped bass (Morone saxatilis x M chrysops). We found that these endobiotics, which we had previously named histone-like proteins (HLPs), exhibited potent activity against Amyloodinium and that the putative levels of HLPs in the skin were well within the levels that we found to be lethal to the parasite in vitro. We also found evidence for the presence of similar antibiotics in sea bream (Sparus aurata) and Mediterranean sea bass (Dicentrarchus labrax). We also examined the effect of chronic stress on the expression of HLP in fish and found that HLP levels were dramatically decreased after only one week of a crowding/high ammonia sublethal stress. We also began to explore the feasibility of upregulating endobiotics via immunostimulation. However, we did not pursue this objective as fully as we originally intended because we spent a much larger effort than originally anticipated on the last objective, the attempted isolation of novel endobiotics from hybrid striped bass. In this regard, we purified and identified four new peptide endobiotics. These endobiotics, which we have named piscidins (from "Pisces" meaning fish), have potent, broad-spectrum activity against a number of both fish and human pathogens. This includes not only parasites but also bacteria. We also demonstrated that these peptides are present in the mast cell. This was the first time that the mast cell, the most common tissue granulocyte in vertebrates, was shown to possess any type of endobiotic. This finding has important implications in explaining the possible function of mast cells in the immune response of vertebrates. In summary, the research we have accomplished in this BARD project has demonstrated that endobiotics in fish have potent activity against many serious pathogens in aquaculture and that there is considerable potential to use these compounds as stress indicators in aquaculture. There is also considerable potential to use some of these compounds in other areas of medicine, including treatment of serious infectious diseases of humans and animals.
APA, Harvard, Vancouver, ISO, and other styles
7

Cahaner, Avigdor, Susan J. Lamont, E. Dan Heller, and Jossi Hillel. Molecular Genetic Dissection of Complex Immunocompetence Traits in Broilers. United States Department of Agriculture, August 2003. http://dx.doi.org/10.32747/2003.7586461.bard.

Full text
Abstract:
Objectives: (1) Evaluate Immunocompetence-OTL-containing Chromosomal Regions (ICRs), marked by microsatellites or candidate genes, for magnitude of direct effect and for contribution to relationships among multiple immunocompetence, disease-resistance, and growth traits, in order to estimate epistatic and pleiotropic effects and to predict the potential breeding applications of such markers. (2) Evaluate the interaction of the ICRs with genetic backgrounds from multiple sources and of multiple levels of genetic variation, in order to predict the general applicability of molecular genetic markers across widely varied populations. Background: Diseases cause substantial economic losses to animal producers. Emerging pathogens, vaccine failures and intense management systems increase the impact of diseases on animal production. Moreover, zoonotic pathogens are a threat to human food safety when microbiological contamination of animal products occurs. Consumers are increasingly concerned about drug residues and antibiotic- resistant pathogens derived from animal products. The project used contemporary scientific technologies to investigate the genetics of chicken resistance to infectious disease. Genetic enhancement of the innate resistance of chicken populations provides a sustainable and ecologically sound approach to reduce microbial loads in agricultural populations. In turn, animals will be produced more efficiently with less need for drug treatment and will pose less of a potential food-safety hazard. Major achievements, conclusions and implications:. The PI and co-PIs had developed a refined research plan, aiming at the original but more focused objectives, that could be well-accomplished with the reduced awarded support. The successful conduct of that research over the past four years has yielded substantial new information about the genes and genetic markers that are associated with response to two important poultry pathogens, Salmonella enteritidis (SE) and Escherichia coli (EC), about variation of immunocompetence genes in poultry, about relationships of traits of immune response and production, and about interaction of genes with environment and with other genes and genetic background. The current BARD work has generated a base of knowledge and expertise regarding the genetic variation underlying the traits of immunocompetence and disease resistance. In addition, unique genetic resource populations of chickens have been established in the course of the current project, and they are essential for continued projects. The US laboratory has made considerable progress in studies of the genetics of resistance to SE. Microsatellite-marked chromosomal regions and several specific genes were linked to SE vaccine response or bacterial burden and the important phenomenon of gene interaction was identified in this system. In total, these studies demonstrate the role of genetics in SE response, the utility of the existing resource population, and the expertise of the research group in conducting such experiments. The Israeli laboratories had showed that the lines developed by selection for high or low level of antibody (Ab) response to EC differ similarly in Ab response to several other viral and bacterial pathogens, indicating the existence of a genetic control of general capacity of Ab response in young broilers. It was also found that the 10w-Ab line has developed, possibly via compensatory "natural" selection, higher cellular immune response. At the DNA levels, markers supposedly linked to immune response were identified, as well as SNP in the MHC, a candidate gene responsible for genetic differences in immunocompetence of chickens.
APA, Harvard, Vancouver, ISO, and other styles
8

Ohad, Nir, and Robert Fischer. Regulation of plant development by polycomb group proteins. United States Department of Agriculture, January 2008. http://dx.doi.org/10.32747/2008.7695858.bard.

Full text
Abstract:
Our genetic and molecular studies have indicated that FIE a WD-repeat Polycomb group (PcG) protein takes part in multi-component protein complexes. We have shown that FIE PcG protein represses inappropriate programs of development during the reproductive and vegetative phases of the Arabidopsis life cycle. Moreover, we have shown that FIE represses the expression of key regulatory genes that promote flowering (AG and LFY), embryogenesis (LEC1), and shoot formation (KNAT1). These results suggest that the FIE PcG protein participates in the formation of distinct PcG complexes that repress inappropriate gene expression at different stages of plant development. PcG complexes modulate chromatin compactness by modifying histones and thereby regulate gene expression and imprinting. The main goals of our original project were to elucidate the biological functions of PcG proteins, and to understand the molecular mechanisms used by FIE PcG complexes to repress the expression of its gene targets. Our results show that the PcG complex acts within the central cell of the female gametophyte to maintain silencing of MEA paternal allele. Further more we uncovered a novel example of self-imprinting mechanism by the PgG complex. Based on results obtained in the cures of our research program we extended our proposed goals and elucidated the role of DME in regulating plant gene imprinting. We discovered that in addition to MEA,DME also imprints two other genes, FWA and FIS2. Activation of FWA and FIS2 coincides with a reduction in 5-methylcytosine in their respective promoters. Since endosperm is a terminally differentiated tissue, the methylation status in the FWA and FIS2 promoters does not need to be reestablished in the following generation. We proposed a “One-Way Control” model to highlight differences between plant and animal genomic imprinting. Thus we conclude that DEMETER is a master regulator of plant gene imprinting. Future studies of DME function will elucidate its role in processes and disease where DNA methylation has a key regulatory role both in plants and animals. Such information will provide valuable insight into developing novel strategies to control and improve agricultural traits and overcome particular human diseases.
APA, Harvard, Vancouver, ISO, and other styles
9

Chejanovsky, Nor, and Bruce A. Webb. Potentiation of Pest Control by Insect Immunosuppression. United States Department of Agriculture, January 2010. http://dx.doi.org/10.32747/2010.7592113.bard.

Full text
Abstract:
The restricted host range of many baculoviruses, highly pathogenic to Lepidoptera and non-pathogenic to mammals, limits their use to single or few closely related Lepidopteran species and is an obstacle to extending their implementation for pest control. The insect immune response is a major determinant of the ability of an insect pathogen to efficiently multiply and propagate. We have developed an original model system to study the Lepidopteran antiviral immune response based on Spodoptera littoralis resistance to AcMNPV (Autographa californica multiple nucleopolyhedrovirus) infection and the fascinating immunosuppressive activity of polydnaviruses .Our aim is to elucidate the mechanisms through which the immunosuppressive insect polydnaviruses promote replication of pathogenic baculoviruses in lepidopteran hosts that are mildly or non-permissive to virus- replication. In this study we : 1- Assessed the extent to which and the mechanisms whereby the immunosuppressive Campoletis sonorensis polydnavirus (CsV) or its genes enhanced replication of a well-characterized pathogenic baculovirus AcMNPV, in polydnavirus-immunosuppressedH. zea and S. littoralis insects and S. littoralis cells, hosts that are mildly or non-permissive to AcMNPV. 2- Identified CsV genes involved in the above immunosuppression (e.g. inhibiting cellular encapsulation and disrupting humoral immunity). We showed that: 1. S. littoralis larvae mount an immune response against a baculovirus infection. 2. Immunosuppression of an insect pest improves the ability of a viral pathogen, the baculovirus AcMNPV, to infect the pest. 3. For the first time two PDV-specific genes of the vankyrin and cystein rich-motif families involved in immunosuppression of the host, namely Pvank1 and Hv1.1 respectively, enhanced the efficacy of an insect pathogen toward a semipermissive pest. 4. Pvank1 inhibits apoptosis of Spodopteran cells elucidating one functional aspect of PDVvankyrins. 5. That Pvank-1 and Hv1.1 do not show cooperative effect in S. littoralis when co-expressed during AcMNPV infection. Our results pave the way to developing novel means for pest control, including baculoviruses, that rely upon suppressing host immune systems by strategically weakening insect defenses to improve pathogen (i.e. biocontrol agent) infection and virulence. Also, we expect that the above result will help to develop systems for enhanced insect control that may ultimately help to reduce transmission of insect vectored diseases of humans, animals and plants as well as provide mechanisms for suppression of insect populations that damage crop plants by direct feeding.
APA, Harvard, Vancouver, ISO, and other styles
10

Chejanovsky, Nor, and Bruce A. Webb. Potentiation of pest control by insect immunosuppression. United States Department of Agriculture, July 2004. http://dx.doi.org/10.32747/2004.7587236.bard.

Full text
Abstract:
Our original aims were to elucidate the mechanisms through which the immunosuppressive insect virus, the Campoletis sonorensis polydnavirus (CsV) promotes replication of a well-characterized pathogenic virus, the Autographa californica multiple nucleopolyhedrovirus (AcMNPV) in hosts that are mildly or non-permissive to virus replication. According to the BARD panels criticism we modified our short-term goals (see below). Thus, in this feasibility study (one-year funding) we aimed to show that: 1. S. littoralis larvae mount an immune response against a baculovirus infection. 2. Immunosuppression of an insect pest improves the ability of a viral pathogen (a baculovirus) to infect the pest. 3. S. littoralis cells constitute an efficient tool to study some aspects of the anti- viral immune response. We achieved the above objectives by: 1. Finding melanized viral foci upon following the baculoviral infection in S . littoralis larvae infected with a polyhedra - positive AcMNPV recombinant that expressed the GFP gene under the control of the Drosophila heat shock promoter. 2. Studying the effect of AcMNPV-infection in S . littoralis immunosuppressed by parasitation with the Braconidae wasp Chelonus inanitus that bears the CiV polydna virus, that resulted in higher susceptibility of S. littoralis to AcMNPV- infection. 3. Proving that S. littoralis hemocytes resist AcMNPV -infection. 4. Defining SL2 as a granulocyte-like cell line and demonstrating that as littoralis hemocytic cell line undergoes apoptosis upon AcMNPV -infection. 5. Showing that some of the recombinant AcMNPV expressing the immuno-suppressive polydna virus CsV- vankyrin genes inhibit baculoviral-induced lysis of SL2 cells. This information paves the way to elucidate the mechanisms through which the immuno- suppressive polydna insect viruses promote replication of pathogenic baculoviruses in lepidopteran hosts that are mildly or non-permissive to virus- replication by: - Assessing the extent to which and the mechanisms whereby the immunosuppressive viruses, CiV and CsV or their genes enhance AcMNPV replication in polydnavirus- immunosuppressed H. zea and S. littoralis insects and S. littoralis cells. - Identifying CiV and CsV genes involved in the above immunosuppression (e.g. inhibiting cellular encapsulation and disrupting humoral immunity). This study will provide insight to the molecular mechanisms of viral pathogenesis and improve our understanding of insect immunity. This knowledge is of fundamental importance to controlling insect vectored diseases of humans, animals and plants and essential to developing novel means for pest control (including baculoviruses) that strategically weaken insect defenses to improve pathogen (i.e. biocontrol agent) infection and virulence.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Mycoplasma diseases in animals' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography